OS Therapies Incorporated (OSTX)

OS Therapies Statistics

Total Valuation

OS Therapies has a market cap or net worth of $33.15 million. The enterprise value is $27.61 million.

Market Cap	33.15M
Enterprise Value	27.61M

Important Dates

The next estimated earnings date is Thursday, May 15, 2025, before market open.

Earnings Date	May 15, 2025
Ex-Dividend Date	n/a

Share Statistics

OS Therapies has 21.66 million shares outstanding. The number of shares has increased by 127.97% in one year.

Current Share Class	21.66M
Shares Outstanding	21.66M
Shares Change (YoY)	+127.97%
Shares Change (QoQ)	+36.87%
Owned by Insiders (%)	30.58%
Owned by Institutions (%)	0.67%
Float	12.24M

Valuation Ratios

PE Ratio	n/a
Forward PE	2.26
PS Ratio	n/a
Forward PS	n/a
PB Ratio	40.85
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.20

Current Ratio	1.20
Quick Ratio	1.20
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3.32

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-134.41%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-747.55%
Revenue Per Employee	n/a
Profits Per Employee	-$2.18M
Employee Count	5
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	1.63
200-Day Moving Average	n/a
Relative Strength Index (RSI)	50.31
Average Volume (20 Days)	150,092

Short Selling Information

The latest short interest is 8,931, so 0.04% of the outstanding shares have been sold short.

Short Interest	8,931
Short Previous Month	n/a
Short % of Shares Out	0.04%
Short % of Float	0.07%
Short Ratio (days to cover)	0.01

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-6.81M
Pretax Income	n/a
Net Income	-10.89M
EBITDA	-6.81M
EBIT	-6.81M
Earnings Per Share (EPS)	-$0.88

Balance Sheet

The company has $5.53 million in cash and n/a in debt, giving a net cash position of $5.53 million or $0.26 per share.

Cash & Cash Equivalents	5.53M
Total Debt	n/a
Net Cash	5.53M
Net Cash Per Share	$0.26
Equity (Book Value)	811,487
Book Value Per Share	-0.25
Working Capital	906,217

Cash Flow

Operating Cash Flow	-7.28M
Capital Expenditures	n/a
Free Cash Flow	-7.28M
FCF Per Share	-$0.34

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

OS Therapies does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-127.97%
Shareholder Yield	n/a
Earnings Yield	-32.84%
FCF Yield	-21.97%

Analyst Forecast

The average price target for OS Therapies is $18.00, which is 1,124.49% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$18.00
Price Target Difference	1,124.49%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2